Outcomes of hematopoietic cell transplantation in thalassemia from the EBMT, 2000 to 2010

Recipient age and donor characteristics	Two-year overall survival (%)	Two-year thalassemia-free survival (%)
Recipient age <14 years	90 to 96	83 to 93
Recipient age 14 years or older	80 to 82	74 to 76
Matched sibling donor	91	83
Matched family donor other than sibling	88	78
Mismatched family donor	68	68
Matched unrelated donor	77	77

Refer to UpToDate for further information about the use of HCT in thalassemia.

EBMT: European Society for Blood and Marrow Transplantation; HCT: Hematopoietic cell transplant.

Data from: Baronciani D, Angelucci E, Potschger U, et al. Hemopoietic stem cell transplantation in thalassemia: A report from the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Registry, 2000-2010. Bone Marrow Transplant 2016; 51:536.

Graphic 52120 Version 8.0

خرید پکیج

Outcomes of hematopoietic cell transplantation in thalassemia from the EBMT, 2000 to 2010